Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

AB 1081Sesión 2025

Relating to: modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. (FE)

Bill Text

Skip navigation
  • Home
  • Documents
  • Senate
  • Assembly
  • Committees
  • Service Agencies
  • Docs
  • Options
  • Help
  • 2025 Biennium
  • Statutes
  • Admin. Rules
  • Indices
  • Miscellaneous
  • Archives
  • Home
  • Bill, Rule, and Appointment Histories
  • Senators
  • Representatives
  • Committees
  • Text of Introduced Proposals
  • Amendment Text
  • Acts
  • Veto Messages
  • Enrolled Bills
  • Votes
  • Assembly and Senate Floor Calendars
  • Schedule of Committee Activities
  • Assembly and Senate Journals
  • Committee Records (ROCPs)
  • Legislative Rules
  • All Session-Related Documents
  • Subject Index to Acts
  • Subject Index to Legislation
  • Subject Index to Journals
  • Author Index to Legislation
  • Subject Index to Clearinghouse Rules
  • Miscellaneous Budget Documents
  • Executive Orders
  • Rulings of the Chair
  • Wisconsin Supreme Court Rules
  • Opinions of the Attorney General
  • Town Law Forms
  • Law
  • Districts
  • Session
  • Drafting Files
  • Feeds
  • Preferences
  • Show tree
  • Hide tree
  • Feedback
  • Help
  • Home
  • Senate Home
  • Senators
  • Committees
  • Session
  • Chief Clerk
  • Sergeant at Arms
  • Civics Education
  • Human Resources
  • Assembly Home
  • Representatives
  • Committees
  • Session
  • Chief Clerk
  • Sergeant at Arms
  • Human Resources
  • Schedule
  • Joint
  • Senate
  • Assembly
  • Study
  • Legislative Audit Bureau
  • Legislative Council
  • Legislative Fiscal Bureau
  • Legislative Human Resources Office
  • Legislative Reference Bureau
  • Legislative Technology Services Bureau
  • Menu
  • »2025
  • »Related Documents
  • »Proposal Text
  • »AB1081: Bill Text
Up Up 2025 - 2026 LEGISLATURELRB-5946/1SWB:wlj2025 ASSEMBLY BILL 1081February 26, 2026 - Introduced by Representatives Kurtz, Dittrich, Duchow, Knodl, Maxey, Moses, Mursau, Nedweski, Novak, O'Connor, Rodriguez, Snodgrass and Steffen, cosponsored by Senators Testin, James and Wanggaard. Referred to Committee on Mental Health and Substance Abuse Prevention.AB1081,1,41An Act to create 51.422 (4) of the statutes; relating to: modifying
2administrative rules relating to regulation of opioid treatment programs and
3requiring adjustments to the rates for substance use disorder treatment
4services with medications for opioid use disorder.Analysis by the Legislative Reference BureauThis bill makes various changes to administrative rules promulgated by the Department of Health Services relating to the regulation of opioid treatment programs (OTPs). Among other things, the bill eliminates a requirement in current administrative rules that persons under the age of 18 have a one-year opioid addiction history and two documented instances of unsuccessful treatment in order to be admitted to an OTP.Mirroring federal regulations, the bill creates an administrative rule defining “practitioner” as a health care professional who is appropriately licensed by a state to prescribe or dispense medications for opioid use disorders and, as a result, is authorized to practice within an OTP. The bill then also expands certain administrative rules that reference physicians to instead refer to practitioners.The bill modifies current administrative rules to provide that screening examinations for admission to an OTP may be completed by a non-OTP practitioner up to seven days prior to admission and that a full examination must be completed within 14 days and may be completed by a non-OTP practitioner with review by an OTP provider.Under current administrative rules, an OTP must have a registered nurse on staff to supervise the dosing process, and a registered nurse must be physically on the premises any time dosing is occurring. The bill modifies this rule, eliminating the requirement for a registered nurse to be on site any time dosing is occurring and allowing either a registered nurse or licensed practical nurse to administer medication.The bill repeals administrative rules relating to take-home medications and replaces those rules with new rules relating to the criteria for unsupervised use of medication for the treatment of opioid use disorders, restrictions for unsupervised use of methadone hydrochloride, and certain exceptions to those restrictions. Under the administrative rules created by the bill, a patient in an OTP may receive their individual take-home doses as ordered for days that the clinic is closed for business, on one weekend day, and on state and federal holidays, no matter their length of time in treatment, as permitted by federal regulations. For take-home doses beyond that, a practitioner must review and document the criteria set forth under federal regulations when determining whether dispensing medication for a patient’s unsupervised use is safe and it is appropriate to set, increase, or extend the amount of time between visits to the OTP. That determination, including the basis for the determination, must be documented by a practitioner in the patient’s medical record. Under the rules established by the bill, if a practitioner assesses, determines, and documents that a patient meets the federal criteria and can safely manage unsupervised doses of methadone, the number of take-home doses is limited by federal regulations. When a practitioner has reason to accelerate the number of unsupervised doses of methadone hydrochloride, they must comply with the requirements under applicable federal regulations and the criteria for unsupervised use and must use the exception process provided by the federal Center for Substance Abuse Treatment Division of Pharmacologic Therapies. The bill establishes a rule that DHS has the authority to monitor a program for compliance with federal regulations and may take licensing actions on the basis of a DHS determination of noncompliance.Current administrative rules generally require patients receiving guest dosing (administration of a medication used for the treatment of opioid addiction to a person who is not a client of the program that is administering or dispensing the medication) to have been enrolled at their home clinic for a minimum of 30 days before being eligible for a guest dose. The bill eliminates that requirement.With certain limited exceptions, current administrative rules provide that the maximum initial dose of methadone may not exceed 30 milligrams. The bill increases the maximum initial dose to 50 milligrams, unless the practitioner finds sufficient medical rationale, including if the patient is transferring from another OTP on a higher dose that has been verified, and documents in the patient’s record that a higher dose was clinically indicated. The bill also changes the current rule regarding the maximum number of days during any 12-month period that an individual may be provided interim maintenance treatment from 120 days to 180 days.The bill creates a new administrative rule that an OTP may provide split dosing when, in the clinical judgment of the OTP practitioner, such dosing is medically appropriate. Under the bill, the practitioner’s determination and clinical rationale must be documented in the patient’s medical record. The new administrative rule created by the bill provides that no additional testing or documentation beyond routine clinical practice may be required, and any laboratory testing must be at the discretion of the practitioner.Under current administrative rules, an OTP must employ at least one substance abuse counselor, substance abuse counselor-in training, licensed marriage and family therapist, licensed professional counselor, licensed clinical social worker, certified advanced practice social worker, certified independent social worker, or clinical substance abuse counselor who is under the supervision of a clinical supervisor. The rules also provide that an OTP must employ such a clinician for a minimum of one full-time equivalent of 40 hours per week for every 55 enrolled patients in the service. The bill eliminates that requirement.The bill also requires DHS to update, each January 1, beginning January 1, 2027, the rates for substance use disorder treatment services with medications for opioid use disorder to be equivalent to the corresponding state-specific, locality-adjusted Medicare rates for the same or comparable services in the calendar year in which the services are provided. The bill provides that those rates do not apply to federally qualified health centers, rural health centers, Indian health services facilities, or certified community behavioral health centers.For further information see the state fiscal estimate, which will be printed as an appendix to this bill.The people of the state of Wisconsin, represented in senate and assembly, do enact as follows:AB1081,11Section 1. 51.422 (4) of the statutes is created to read:AB1081,2,8251.422 (4) Rate updates. Each January 1, beginning January 1, 2027, the
3department shall update the rates for substance use disorder treatment services
4with medications for opioid use disorder to be equivalent to the corresponding state-
5specific, locality-adjusted Medicare rates for the same or comparable services in the
6calendar year in which the services are provided. The rates established under this
7subsection do not apply to federally qualified health centers, rural health centers,
8Indian health services facilities, or certified community behavioral health centers.AB1081,21Section 2. DHS 75.59 (3) (nm) of the administrative code is created to read:AB1081,3,42DHS 75.59 (3) (nm) “Practitioner” means a health care professional who is
3appropriately licensed by a state to prescribe or dispense medications for opioid use
4disorders and, as a result, is authorized to practice within an OTP.AB1081,35Section 3. DHS 75.59 (5) (b) of the administrative code is amended to read:AB1081,3,236DHS 75.59 (5) (b) Medical director. The service shall designate a physician
7licensed under ch. 448, Stats., as its medical director. The medical director shall
8have at least one year of experience in addiction medicine or addiction psychiatry,
9be licensed to practice medicine or osteopathy, and meet all other requirements
10listed in s. DHS 75.03 (52). If a service is not able to secure a medical director who
11meets the one year of experience requirement, as documented through recruitment
12efforts, there shall be a specific plan for the person to acquire equivalent training
13and skills within 4 months after beginning employment. The medical director,
14service physician, or mid-level practitioner that has a federal exception approved by
15SAMHSA and the SOTA to 42 CFR 8.12 (b), (e), (h), and (i) shall be physically
16present at the OTP at least 40 percent of the time that the program administers or
17dispenses medication in order to comply with s. DHS 94.08, assure regulatory
18compliance, and carry out duties specifically assigned by regulation as required by
19SAMHSA under 42 CFR 8.12. OTPs in the first 60 days of operation may reduce the
20time requirement medical directors or practitioners must be present on site to at
21least 20 percent of the time that the program administers or dispenses medication.
22On the 61st day of operation the service shall be subject to the requirements of this
23rule.AB1081,424Section 4. DHS 75.59 (5) (c) of the administrative code is amended to read:AB1081,4,41DHS 75.59 (5) (c) Nurses. The service shall have a registered nurse or
2licensed practical nurse on staff to supervise the dosing process and perform other
3functions delegated by the physician. A registered nurse shall be physically on the
4premises any time dosing is occurring.AB1081,55Section 5. DHS 75.59 (5) (e) of the administrative code is amended to read:AB1081,4,146DHS 75.59 (5) (e) Licensed counselors. The service shall employ at least one
7of the following: substance abuse counselors, substance abuse counselors-in
8training, licensed marriage and family therapists, licensed professional counselors,
9licensed clinical social workers, certified advanced practice social workers, certified
10independent social workers, or clinical substance abuse counselors who are under
11the supervision of a clinical supervisor. An OTP shall employ one of these
12identified clinicians for a minimum of one full-time equivalent of 40 hours per week
13for every 55 enrolled patients in the service. All counselors rostered to the service
14are subject to this ratio.AB1081,615Section 6. DHS 75.59 (6) (a) 1. of the administrative code is amended to
16read:AB1081,5,217DHS 75.59 (6) (a) 1. ‘Maintenance treatment for an adult.’ The service shall
18maintain current procedures determined by the service physician to ensure that
19patients are admitted to maintenance treatment by qualified personnel who have
20determined, using accepted medical criteria, such as those listed in the DSM, that
21the person is currently addicted to an opioid drug, and that the person became
22addicted at least one year before admission for treatment. In addition, a service
23physician shall ensure that each patient voluntarily chooses maintenance
24treatment and that all relevant facts concerning the use of the opioid drug are
1clearly and adequately explained to the patient, and that each patient provides
2informed written consent to treatment.AB1081,73Section 7. DHS 75.59 (6) (a) 2. of the administrative code is amended to
4read:AB1081,5,105DHS 75.59 (6) (a) 2. ‘Maintenance treatment for a minor.’ A minor shall be
6eligible for maintenance treatment only if the minor has had at least 2 documented
7unsuccessful attempts at short-term detoxification or drug-free treatment within a
812-month period. No minor may be admitted to maintenance treatment unless a
9parent, legal guardian, or responsible adult designated by the relevant state
10authority consents in writing to such treatment.AB1081,811Section 8. DHS 75.59 (6) (a) 3. of the administrative code is repealed.AB1081,912Section 9. DHS 75.59 (6) (e) of the administrative code is amended to read:AB1081,5,2413DHS 75.59 (6) (e) 1. For each patient eligible for admission, the service shall
14arrange for a comprehensive physical examination and clinically indicated
15laboratory work-up. The comprehensive physical examination shall be ordered by
16the service physician practitioner on the day of admission and shall include a
17complete blood count and liver function testing. The service shall test for Hepatitis
18A, B, C and HIV if the patient gives informed consent in writing. If the patient
19declines permission to test shall be documented in the patient’s record. Screening
20examinations may be completed by a non-OTP practitioner up to 7 days prior to
21admission. Full examination must be completed within 14 days and may be
22completed by a non-OTP practitioner with review by an OTP provider. An updated
23comprehensive physical examination including lab work shall be completed
24annually.AB1081,101Section 10. DHS 75.59 (6) (f) of the administrative code is amended to read:AB1081,6,112DHS 75.59 (6) (f) Initial dose. If a person meets the admission criteria under
3par. (a), an initial dose of an FDA-approved medication may be administered to the
4patient on the day of admission. For each new patient enrolled in a service, the
5initial dose of methadone shall not exceed 30 50 milligrams and the total dose for
6the first day shall not exceed 40 milligrams, unless the service physician documents
7in the patient’s record that 40 milligrams did not suppress opioid abstinence
8symptoms milligrams, unless the practitioner finds sufficient medical rationale,
9including if the patient is transferring from another OTP on a higher dose that has
10been verified, and documents in the patient’s record that a higher dose was
11clinically indicated.AB1081,1112Section 11. DHS 75.59 (6) (i) 3. of the administrative code is amended to
13read:AB1081,6,1514DHS 75.59 (6) (i) 3. Determines and verifies the patient’s age. If the patient
15is a minor, the policy shall require documentation as provided in par. (a) 2.AB1081,1216Section 12. DHS 75.59 (11) (a) of the administrative code is amended to
17read:AB1081,6,2118DHS 75.59 (11) (a) Dose determination. The dose determination for a patient,
19including if split dosing is appropriate, is a matter of clinical judgment by a
20physician practitioner in consultation with the patient and appropriate clinical
21staff.AB1081,1322Section 13. DHS 75.59 (11) (f) of the administrative code is amended to read:AB1081,7,523DHS 75.59 (11) (f) Initial methadone dose. A patient’s initial dose shall be
24based on the service physician’s practitioner’s evaluation of the history and present
1condition of the patient. The initial dose of methadone may not exceed 30 50
2milligrams except that the total dose for the first day may not exceed 40 milligrams,
3unless the practitioner finds sufficient medical rationale, including if the patient is
4transferring from another OTP on a higher dose that has been verified, and
5documents in the patient’s record that a higher dose was clinically indicated.AB1081,146Section 14. DHS 75.59 (11) (h) of the administrative code is created to read:AB1081,7,127DHS 75.59 (11) (h) Split dosing. An OTP may provide split dosing when, in
8the clinical judgment of the OTP practitioner, such dosing is medically appropriate.
9The practitioner’s determination and clinical rationale shall be documented in the
10patient’s medical record. No additional testing or documentation beyond routine
11clinical practice may be required, and any laboratory testing, including peak and
12trough level, shall be at the discretion of the practitioner.AB1081,1513Section 15. DHS 75.59 (13) of the administrative code is repealed and
14recreated to read:AB1081,7,2115DHS 75.59 (13) Criteria for unsupervised use. (a) To limit the potential
16for diversion of medication used for the treatment of opioid use disorder to the illicit
17market, medication dispensed to a patient for unsupervised use shall be subject to
18the requirements under this subsection. Any patient in an OTP may receive their
19individualized take-home doses as ordered for days that the clinic is closed for
20business, on one weekend day, and on state and federal holidays, no matter their
21length of time in treatment, as allowed under 42 CFR 8.12 (i) (1).AB1081,8,222(b) For take-home doses beyond those allowed under par. (a), a practitioner
23shall review and document the criteria under 42 CFR 8.12 (i) (2) when determining
24whether dispensing medication for a patient’s unsupervised use is safe and it is
1appropriate to set, increase, or extend the amount of time between visits to the
2OTP.AB1081,8,43(c) A determination under par. (b), including the basis of the determination,
4shall be documented by a practitioner in the patient’s medical record.AB1081,165Section 16. DHS 75.59 (14) of the administrative code is repealed and
6recreated to read:AB1081,8,117DHS 75.59 (14) Restrictions for unsupervised use of methadone
8hydrochloride. If a practitioner assesses, determines, and documents that a
9patient meets the criteria under sub. (13) and that a patient can safely manage
10unsupervised doses of methadone, the number of take-home doses the patient
11receives shall be limited by the number allowed under 42 CFR 8.12 (i) (3).AB1081,1712Section 17. DHS 75.59 (14m) of the administrative code is created to read:AB1081,8,2013DHS 75.59 (14m) Restriction exceptions. When a practitioner has reason
14to accelerate the number of unsupervised use doses of methadone hydrochloride,
15the practitioner shall comply with the requirements under 42 CFR 8.12 and the
16criteria for unsupervised use and shall use the exception process provided by the
17federal center for substance abuse treatment division of pharmacologic therapies.
18For the purposes of enforcement of this subsection, the department has authority to
19monitor an OTP for compliance with federal regulations and may take licensing
20actions on the basis of the department’s determination of noncompliance.AB1081,1821Section 18. DHS 75.59 (16) (a) 8. of the administrative code is repealed. Down Down /2025/related/proposals/ab1081 true proposaltext /2025/related/proposals/ab1081 proposaltext/2025/REG/AB1081 proposaltext/2025/REG/AB1081 section true
  • Menu
  • »2025
  • »Related Documents
  • »Proposal Text
  • »AB1081: Bill Text
× Details for
PDF view
Link (Permanent link)
Bookmark this location
View toggle
Go to top of document
Search in this chapter
Search in this section
Search in this agency
Search in this chapter group
Search in this chapter
Search in this section
Cross references for section
Acts affecting this section
References to this
1970 Statutes Annotations
Appellate Court Citations
Administrative Code Index
Reference lines
Clear highlighting

Texto oficial de la Legislatura de Wisconsin. El formato se adaptó para leerlo en Ratifi.